In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 EMAIL TO FRIEND     |      PRINTER FRIENDLY     |    
          advertisement

Group B Strep Down Among Newborns, Up Among Adults

May 9 (HealthDay News) -- Instances of Group B streptococcus, a major cause of serious infections, have dropped by about 25 percent among week-old infants, but rose by almost 50 percent among most adults during a recent six-year period, according to a new study.

Group B strep is the leading cause of sepsis and meningitis in the first week of life. Prevention strategies put in place during the 1970s have helped quell the condition, called early-onset disease. However, an estimated 21,500 cases of invasive disease and 1,700 deaths were traced to the disease during 2005, according to the study, published in the May 7 issue of Journal of American Medical Association.

Group B streptococcus can also cause invasive disease in older infants, pregnant women, children and young adults with underlying medical conditions and older adults. An increase in disease incidence among non-pregnant adults has been previously documented in past decades.

The new study, which examines data on laboratory-confirmed invasive group B streptococcal disease in 10 states from 1999 to 2005, found 14,573 cases of the disease overall. Of those, 1,232 cases where early-onset disease.

Incidence decreased among week-old infants by 27 percent after the early-onset disease prevention guidelines were revised in 2002. Incidence remained flat among babies age 7 days to 89 days and pregnant women.

Among those age 15 to 64 years, Group B strep increased 48 percent. Occurrence of the disease increase by 20 percent among those 65 years or older experienced a 20 percent increase.

The proportion of patients who died was highest in the oldest age groups.

All strains of Group B strep tested were vulnerable to the antibiotics penicillin, ampicillin, and vancomycin, but 32 percent and 15 percent were resistant to erythromycin and clindamycin, respectively.

The study's authors concluded that group B streptococcus vaccination trials for mothers should become a priority, followed by vaccine development to help the elderly and younger adults with chronic underlying conditions.


SOURCE: JAMA Archives journals, news release, May 6, 2008

advertisement

Sneeze No More

Sneeze No More

You’ll find it easy to avoid allergies.

Love the outdoors again
advertisement
Home  |  Health Centers  |  Health A-Z  |  Staying Healthy  |  Diet & Fitness  |  Woman & Family  |  Pregnancy  |  Community

also on iVillage: Pregnancy & Parenting  |  Beauty & Style  |  Home & Garden  |  Food  |  Weddings  |  Love  |  Entertainment

Terms of Service  |  Privacy Policy  |  Site Map  |  Newsletters  |  Feedback

Copyright (c) 2000-2008 iVillage Inc. All rights reserved. The information provided on this site is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.